Retatrutide is an investigational triple agonist peptide studied for its interaction with GIP, GLP-1, and glucagon receptors. Its multi-pathway mechanism has made it a subject of ongoing clinical research in metabolic health. For research purposes only.
Retatrutide is an investigational triple agonist peptide studied for its interaction with GIP, GLP-1, and glucagon receptors. Its multi-pathway mechanism has made it a subject of ongoing clinical research in metabolic health.
For research purposes only.
| Quantity | 5mg, 10mg, 15mg, 20mg, 30mg, 40mg, 50mg, 60mg |
|---|
Reviews
There are no reviews yet.